Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $62,373 - $70,720
-1,300 Reduced 2.53%
50,000 $2.71 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $27.7 Million - $33.1 Million
-571,700 Reduced 91.77%
51,300 $2.63 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $38.2 Million - $42.4 Million
600,000 Added 2608.7%
623,000 $39.8 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $1.51 Million - $1.71 Million
23,000 New
23,000 $1.59 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $2.97 Million - $3.27 Million
-40,900 Reduced 16.98%
200,000 $15.4 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $13.1 Million - $15.7 Million
213,500 Added 779.2%
240,900 $17.6 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $11.1 Million - $12.9 Million
-206,400 Reduced 88.28%
27,400 $1.71 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $9.4 Million - $11 Million
158,800 Added 211.73%
233,800 $13.8 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $402,010 - $445,480
-7,000 Reduced 8.54%
75,000 $4.52 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $31.6 Million - $37 Million
-577,300 Reduced 87.56%
82,000 $4.82 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $18.3 Million - $26.6 Million
394,300 Added 148.79%
659,300 $36.8 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $3.2 Million - $4.17 Million
65,000 Added 32.5%
265,000 $17 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $12.2 Million - $15.8 Million
-250,000 Reduced 55.56%
200,000 $10.4 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $13.8 Million - $15.6 Million
250,000 Added 125.0%
450,000 $27.9 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $21.6 Million - $24.8 Million
-360,000 Reduced 64.29%
200,000 $12.7 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $30.9 Million - $35.7 Million
560,000
560,000 $35.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.